HighVista Strategies’s Revolution Medicines RVMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.74M	Sell	69,309 -50,931	-42%	-$5.14M	1.86%	7
2025 Q4	$9.58M	Sell	120,240 -55,208	-31%	-$3.62M	2.47%	6
2025 Q3	$8.19M	Buy	175,448 +107,400	+158%	+$4.21M	2.01%	5
2025 Q2	$2.5M	Sell	68,048 -5,704	-8%	-$219K	0.92%	27
2025 Q1	$2.61M	Buy	73,752 +16,506	+29%	+$670K	1%	18
2024 Q4	$2.5M	Buy	57,246 +1,684	+3%	+$85K	0.93%	28
2024 Q3	$2.52M	Buy	55,562 +15,479	+39%	+$674K	0.87%	34
2024 Q2	$1.56M	Buy	40,083 +25,758	+180%	+$963K	0.57%	64
2024 Q1	$462K	Sell	14,325 -8,325	-37%	-$247K	0.16%	122
2023 Q4	$650K	Buy	22,650 +4,645	+26%	+$112K	0.24%	108
2023 Q3	$498K	Buy	+18,005	New	+$534K	0.23%	108
2022 Q4	–	Sell	-42,056	Closed	-$829K	–	124
2022 Q3	$829K	Buy	42,056 +21,371	+103%	+$470K	0.47%	52
2022 Q2	$403K	Buy	+20,685	New	+$403K	0.24%	81
2021 Q4	–	Sell	-23,637	Closed	-$650K	–	108
2021 Q3	$650K	Sell	23,637 -1,401	-6%	-$40.8K	0.43%	66
2021 Q2	$795K	Buy	25,038 +8,046	+47%	+$281K	0.56%	52
2021 Q1	$780K	Buy	+16,992	New	+$762K	0.58%	30